Semaglutide targets the GLP-1 receptor only, while Tirzepatide targets both GLP-1 and GIP receptors making it a dual-action medication
Physiological and pharmacological data have shown that activation of the GLP1 receptors promotes insulin secretion from pancreatic beta cells and also causes weight loss and thus representing a significant pharmacological target for the treatment of type 2 diabetes (Drucker, 2018
Lopez-Lopez C, LeRoith D, Torres-Aleman I: Insulin-like growth factor I is required for vessel remodeling in the adult brain
No imminent regulatory ban exists
At AlphaMD, we believe in rewarding patients on our platform for spreading the word about high-quality testosterone replacement therapy (TRT)
But if you exhaust your cells by staying in the sauna for too long, you can actually age your cells, according to Dr